Browsing: ADT

Top Line: Relugolix is an oral GnRH antagonist that had superior androgen suppression compared to leuprolide in patients with advanced…

For high risk prostate cancer treated with external beam RT, long-course ADT is associated with better treatment outcomes. In the…

Top Line: The decision to administer or omit short term ADT for intermediate risk prostate cancer isn’t a simple yes…

Top Line: Does short term ADT improve survival in the setting of dose escalated radiation for intermediate risk prostate cancer?The…

How do PARP inhibitors compare to docetaxel in the second line for mCRPC? In TRITON3, men with mCRPC progressing after…

Top Line: Do age and comorbidity influence the benefit of short course ADT for prostate cancer? The Study: Prostate cancer…

Top Line: Does the sequence of short-course ADT and radiation matter when treating prostate cancer? The Study: In 2020, a…

Top Line: Recently, two randomized trials, ARASENS and PEACE-1, showed that triplet therapy for metastatic, castration sensitive prostate cancer improves…

Top Line: Should men receiving salvage prostate fossa radiation also receive ADT and pelvic nodal radiation? The Study: RTOG 9601…